Exercise News and Research

Latest Exercise News and Research

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency's request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.

7 Jan 2016

Mayo Clinic Diet offers weight-loss and lifestyle program based on research, clinical experience

Turning the calendar to a new year often finds people working on their commitment to a healthy lifestyle. When it comes to losing weight, experts advise taking a longer view, beyond a New Year's resolution.

6 Jan 2016

Exercise training could be a new treatment for prostate cancer

A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.

6 Jan 2016

Diet or aerobic exercise improves ability to exercise for obese older patients with heart failure

Among obese older patients with a common type of heart failure, calorie restriction or aerobic exercise training improved their ability to exercise without experiencing shortness of breath, although neither intervention had a significant effect on a measure of quality of life, according to a study in the January 5 issue of JAMA.

6 Jan 2016

Using antidepressant drug during first trimester of pregnancy may increase risk of birth defects

Using paroxetine--a medication prescribed to treat conditions including depression, obsessive-compulsive disorder, anxiety and posttraumatic stress disorder--during the first trimester of pregnancy may increase newborns' risk of congenital malformations and cardiac malformations. That's the conclusion of a recent analysis published in the British Journal of Clinical Pharmacology.

6 Jan 2016

FDA grants Orphan Drug Designation to Ionis Pharmaceuticals' IONIS-HTT Rx for treatment of HD patients

Ionis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to IONIS-HTTRx for the treatment of patients with Huntington's disease (HD).

5 Jan 2016

Pathway Genomics secures over $40 million in Series E financing

Pathway Genomics Corporation, a global precision medicine company with mobile health solutions, today announced it has successfully raised over $40 million in a Series E financing.

5 Jan 2016

Back pain becoming more common in children and adolescents

According to a new literature review in the January issue of the Journal of the American Academy of Orthopaedic Surgeons, it's becoming more common for children and adolescents to seek medical care for back pain. Even with expensive, advanced tests like MRI scans, doctors may not be able to find the exact cause for the pain.

5 Jan 2016

True Wearables launches world's first wireless, fully disposable, single-use pulse oximeter

True Wearables, Inc., a medical device start-up based in Orange County, CA, announced today Oxxiom, the world's first wireless, continuous, fully disposable, single-use pulse oximeter. Oxxiom measures arterial oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).

4 Jan 2016

Diet-to-Go launches new meal plan for individuals with Type 2 diabetes or prediabetes

Diet-to-Go on January 4th announced it has launched a meal plan specifically created for people who have Type 2 diabetes or prediabetes. The plan's calorie-controlled meals will also help people lose and manage their weight.

4 Jan 2016

DATATRAK announces date for 2015 Annual Meeting of Shareholders

DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.

30 Dec 2015

Exercising early in life can alter gut microbes, promote healthier brain and metabolic activity

The human gut harbors a teeming menagerie of over 100 trillion microorganisms, and researchers at the University of Colorado Boulder have discovered that exercising early in life can alter that microbial community for the better, promoting healthier brain and metabolic activity over the course of a lifetime.

30 Dec 2015

New Josie Robertson Surgery Center provides optimal care for patients undergoing cancer surgery

A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center, opened by Memorial Sloan Kettering, exemplifies that transformation: a patient-focused facility that leverages technology and highly trained clinical teams to provide optimal care.

29 Dec 2015

Myostatin antibody shows promise in treating age-related decline in muscle mass and power

A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.

29 Dec 2015

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

PharmAthene, Inc. announced today that the Delaware Supreme Court affirmed the Delaware Court of Chancery's decision to award PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits for SIGA's smallpox antiviral, Tecovirimat.

26 Dec 2015

Healthier weight using genetic data for customized diets and physical activity plans

Some health experts predict that the next big advance in helping overweight people achieve a healthier weight will be to use an individual's genetic data to customize diets and physical activity plans, an approach known as "precision weight loss.

24 Dec 2015

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.

24 Dec 2015

Lower levels of antibodies in saliva linked to increased risk of mortality

New research from the University of Birmingham has found that lower levels of antibodies in saliva are associated with of an elevated risk of mortality, and could be an early indicator of risk.

24 Dec 2015

Working Group identifies many potential genetic contributors to weight loss

In the midst of the holiday season, celebratory get-togethers can mean overindulging on treats and high-calorie foods, leaving many of us struggling to keep off the extra pounds. With as many as two-thirds of American adults already carrying excess weight, and one third with obesity, maintaining weight can be the biggest challenge, say researchers.

24 Dec 2015

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

22 Dec 2015

Exercise News and Research

Latest Exercise News and Research

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

Mayo Clinic Diet offers weight-loss and lifestyle program based on research, clinical experience

Exercise training could be a new treatment for prostate cancer

Diet or aerobic exercise improves ability to exercise for obese older patients with heart failure

Using antidepressant drug during first trimester of pregnancy may increase risk of birth defects

FDA grants Orphan Drug Designation to Ionis Pharmaceuticals' IONIS-HTT Rx for treatment of HD patients

Pathway Genomics secures over $40 million in Series E financing

Back pain becoming more common in children and adolescents

True Wearables launches world's first wireless, fully disposable, single-use pulse oximeter

Diet-to-Go launches new meal plan for individuals with Type 2 diabetes or prediabetes

DATATRAK announces date for 2015 Annual Meeting of Shareholders

Exercising early in life can alter gut microbes, promote healthier brain and metabolic activity

New Josie Robertson Surgery Center provides optimal care for patients undergoing cancer surgery

Myostatin antibody shows promise in treating age-related decline in muscle mass and power

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

Healthier weight using genetic data for customized diets and physical activity plans

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

Lower levels of antibodies in saliva linked to increased risk of mortality

Working Group identifies many potential genetic contributors to weight loss

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

Mastering RNA extraction for plant and fungal research – eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Exercise News and Research

Latest Exercise News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in